Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 studyMatthew S. Davids, Yifan Zhai, Sikander Ailawadhi et al.|Med|2025Cited by 6